FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review
EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, and Pfizer Inc. announced that the US FDA has...
Amri Announces Strategic Alliance To Advance Mass Spectrometry Capabilities For Drug Discovery
AMRI , a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered an alliance with Bruker...
Epinomics to Collaborate with the Parker Institute for Cancer Immunotherapy at Stanford University
Researchers from Epinomics will collaborate with the research team led by Crystal Mackall, MD, director of the Parker Institute for Cancer Immunotherapy at Stanford,...
AMRA announces $9 million investment from Pfizer Venture Investments, Novo Seeds and Industrifonden
Swedish-based digital health company AMRA has announced a $9 million funding round co-led by US-based Pfizer Venture Investments and leading Nordic VC Novo Seeds....
Irvine Scientific Introduces PRIME-XV T Cell CDM for Immunotherapy Applications
Irvine Scientific, a worldwide leader in cell culture media development and manufacturing announced the introduction of PRIME-XV T Cell CDM, the first commercially available...
VistaGen Licenses Stem Cell Technology to New Firm Backed by Big Pharma
VistaGen Therapeutics Inc , a clinical-stage biopharmaceutical company focused on developing new generation therapies for depression and other central nervous system (CNS) disorders announced...
DNA2.0 Inc Becomes ATUM
Now combining DNA synthesis, protein expression and protein engineering capabilities, ATUM delivers full suite of service to speed discovery Founded in 2003 to marry computational...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...